危险系数
射血分数
心力衰竭
医学
安慰剂
随机对照试验
置信区间
不利影响
心脏病学
内科学
替代医学
病理
作者
Iokfai Cheang,Wenming Yao,Yanli Zhou,Xu Zhu,Gehui Ni,Xinyi Lu,Shengen Liao,Rongrong Gao,Fang Zhou,Jiangang Shen,Alice Yeuk Lan Leung,Meng Jiang,Hong Kong,Ling Bai,Ailiman Mahemuti,Haitao Yuan,Yugang Dong,Chun‐Ka Wong,Qinghua Xu,Gaoxing Zhang
出处
期刊：Nature Medicine
[Nature Portfolio]
日期：2024-08-01
卷期号：30 (8): 2295-2302
被引量：19
标识
DOI：10.1038/s41591-024-03169-2
摘要
Previous findings have indicated the potential benefits of the Chinese traditional medicine Qiliqiangxin (QLQX) in heart failure. Here we performed a double-blind, randomized controlled trial to evaluate the efficacy and safety of QLQX in patients with heart failure and reduced ejection fraction (HFrEF). This multicenter trial, conducted in 133 hospitals in China, enrolled 3,110 patients with HFrEF with NT-proBNP levels of ≥450 pg ml
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
HEIKU
剑指东方是为谁
ceeray23
Caili
huahero2025
nenoaowu
andong
黄bb
默默地读文献
今天只做一件事
echopussy
期待未来的自己
斯寜
余味
wuludie
美好斓
Xiaoxiao
herococa
昏睡的蟠桃
皖公网安备34019202002308
